WHAT IS IT ABOUT?
NEW in 2023, the yearly Pfizer Oncology Award is intended to support, recognise and encourage two innovative projects in Belgium or Luxembourg that improve the quality and/or availability of patient care in oncology:
1. The “classical” Oncology Award of 20.000€ will reward a project focusing on oncology and/or hematology patient care.
2. A NEW Oncology/Covid Award of 10.000€ will reward a project focusing on oncology and/or hematology patient care, specifically associated with Covid-19.
The Pfizer Oncology & Oncology/Covid Awards are open to any project related to the clinical, surgical and medical or technical aspects of patient care in oncology and/or hematology, but also to different ways of collaboration and/or organisation between various health care providers or between levels of care during the course of the disease.
WHO IS IT FOR?
The Pfizer Oncology Award is inviting health care professionals who are linked to a hospital, a network of hospitals, a university, a certified medical centre or a registered scientific society in Belgium or Luxembourg to submit a project which meets the required criteria (for all details please go to the Rules page).
The project must aim at improving the quality and/or availability of oncology patient care in Belgium or Luxembourg.
The project may not already be in the implementation phase, but should be in a conceptual or design phase and should start within the year following the distribution of the award.
A set of rules including pre-defined selection criteria has been developed by an independent Scientific Committee who will select the winning project.
WHO IS THE JURY ?
PROF. SYLVIE ROTTEY, MD, PhD
Medical Oncologist, Clinical Pharmacologist
Head of the department of Medical Oncology Gent University Hospital
Head of the Drug Research Unit GentPROF. AHMAD AWADA, MD, PhD
Head of the Medical Oncology
Clinic at Jules Bordet Institute BrusselsDR. GUY BERCHEM MD, PhD
Medical Oncologist, Head
Oncology Platform Centre Hospitalier de Luxembourg (CHL) President Luxembourg National Institute of Cancer (INC)MR. PATRICK CROMBEZ RN, AOCNS, MSCN, MHCM, MMCA
Head Nurse Department
of Hematology Bordet Institute Brussels
President of the Belgian Oncology Nursing Society SIO
Executive Board Member European Oncology Nursing SocietyPROF. EM. JACQUES DE GRÈVE, MD, PhD
MR. SVEN D’HAESE, MSC
Coordinator of the Radiotherapy Department of UZ Brussel
Chairman of VVRO (Society for Radiotherapy and Oncology nurses)PROF. GUY JERUSALEM, MD, PhD
Head of Medical Oncology
CHU Sart Tilman LiegePROF. JEAN - FRANCOIS BAURAIN, MD, PhD
Head of Clinic
Responsible of melanoma Clinic
Cliniques universitaires Saint-Luc – BrusselsPROF. DR. HANS PRENEN
Head of Oncology department,
Head of Phase 1 - Clinical Trials
Universitair Ziekenhuis AntwerpenPROF. ANNE DEMOLS, MD, PhD
Department of Gastroenterology and Digestive Oncology,
Hôpital Erasme et Institut Jules Bordet, HUBPROF. PETER VANDENBERGHE, MD, PhD
Head of Department of Haematology,
UZ LeuvenDepartment of Human Genetics,
KU LeuvenDR. LORE DECOSTER, MD, PhD
Medical Oncology
UZ Brussel